Sionna Therapeutics Inc. (SION)
13.70
-1.06 (-7.18%)
At close: Feb 28, 2025, 3:59 PM
13.77
0.55%
After-hours: Feb 28, 2025, 04:00 PM EST
No 1D chart data available
| Bid | 13.65 |
| Market Cap | 582.32M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -1.36 |
| PE Ratio (ttm) | -10.07 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 13.81 |
| Volume | 269,444 |
| Avg. Volume (20D) | 331,892 |
| Open | 14.70 |
| Previous Close | 14.76 |
| Day's Range | 13.21 - 14.98 |
| 52-Week Range | 13.21 - 25.19 |
| Beta | 0.00 |
About SION
Sionna Therapeutics, Inc. is a biopharmaceutical company. The Company provides treatment paradigm for cystic fibrosis patients by developing medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator....
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees NaN
Stock Exchange NASDAQ
Ticker Symbol SION
Website https://www.sionnatx.com/
3 weeks ago · seekingalpha.com
U.S. IPO Weekly Recap: Cement And Cystic Fibrosis Drugs Lead A 6 IPO WeekTwo sizable companies and a handful of small Asian issuers were listed in the US this past week. Four small Asia-based issuers also went public in the US - EPWK Holdings, FBS Global, Plutus Financial ...
4 weeks ago · seekingalpha.com
U.S. IPO Weekly Recap: Active January Closes Out With Several Sizable IPOsFive IPOs listed this week, all of which raised over $100 million; one direct listing and three SPACs also debuted. Four microcaps submitted initial filings this week - Vistek, Awaysis Capital, QMSK T...
